Automated Insulin Dosing Systems or Automated Insulin Delivery Systems? It is Time for Consistency

摘要

A system comprised of an insulin pump connected to a continuous glucose monitor, which delivers doses of insulin determined by a software algorithm has been called an “artificial pancreas” and “closed loop system.” In place of these previously widely used terms, clinicians, researchers, manufacturers, and the United States Food and Drug Administration (FDA) alike have recently been using two different new phrases to describe this type of system. These phrases are “automated insulin dosing" system and “automated insulin delivery” system (both abbreviated as AID). Given that two different phrases are used to identify the same type of automated insulin system and both phrases have the same abbreviation (AID), in the interest of clarity, we believe it is preferable to settle on a single phrase that consistently identifies the letter D in this abbreviation as either “dosing” or “delivery.”